Article
Biotechs Take a Cautious Step Back into the Market
April 25, 2024ArticleBiotechs Take a Cautious Step Back into the Market
April 25, 2024Post-pandemic economic conditions have left biotech initial public offering (IPO) activity in the lurch, but there are signs of a return, with eight IPOs in the first quarter
of 2024 alone compared to 19 in the whole of 2023.
SHARE